NDC 62559-870

Bretylium Tosylate

Bretylium Tosylate

Bretylium Tosylate is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Bretylium Tosylate.

Product ID62559-870_85fef6fb-4f8d-4852-ada7-056b6d45a516
NDC62559-870
Product TypeHuman Prescription Drug
Proprietary NameBretylium Tosylate
Generic NameBretylium Tosylate
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2019-12-11
Marketing CategoryANDA / ANDA
Application NumberANDA204386
Labeler NameANI Pharmaceuticals, Inc.
Substance NameBRETYLIUM TOSYLATE
Active Ingredient Strength50 mg/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 62559-870-11

10 mL in 1 VIAL, SINGLE-DOSE (62559-870-11)
Marketing Start Date2019-12-11
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
BRETYLIUM TOSYLATE50 mg/mL

NDC Crossover Matching brand name "Bretylium Tosylate" or generic name "Bretylium Tosylate"

NDCBrand NameGeneric Name
61916-135Bretylium TosylateBretylium Tosylate
62559-870Bretylium Tosylatebretylium tosylate

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.